GenMark Diagnostics Inc. | Ownership
Companies that own GenMark Diagnostics Inc.
T. Rowe Price Associates, Inc.
8,857,766
15.89%
-30,244
0.01%
06/30/2018
Fidelity Management & Research Co.
7,833,399
14.05%
-111,213
0.01%
06/30/2018
Cadian Capital Management LP
4,479,615
8.03%
-561,518
1.72%
06/30/2018
Putnam Investment Management LLC
3,696,948
6.63%
-710,100
0.06%
06/30/2018
Casdin Capital LLC
3,400,000
6.1%
-450,000
4.03%
06/30/2018
BlackRock Fund Advisors
3,079,847
5.52%
202,830
0%
06/30/2018
The Vanguard Group, Inc.
2,473,855
4.44%
41,020
0%
06/30/2018
JPMorgan Asset Management (UK) Ltd.
2,392,675
4.29%
-418,951
0.02%
06/30/2018
HighTower Advisors LLC
2,315,747
4.15%
-57,551
0.15%
06/30/2018
JPMorgan Investment Management, Inc.
1,860,099
3.34%
-103,184
0.01%
06/30/2018
| Address |
5964 La Place Court
Carlsbad California 92008
United States
|
|
Employees
|
- |
| Website |
http://www.genmarkdx.com |
| Updated |
07/08/2019 |
| GenMark Diagnostics, Inc. is a molecular diagnostics company, which engages in the development and commercialization of proprietary eSensor electrochemical detection technology. It also manufactures, sells, and supports instruments and molecular tests. The company was founded by Jon Faiz Kayyem on February 12, 2010 and is headquartered in Carlsbad, CA. |
